Duchenne Research Fund
  • Home
  • Duchenne facts
  • Our story
  • Our projects
  • News
  • Get involved
    • Get involved
    • Gallery
  • Contact
  • Donate
Select Page

Vamorolone shows improvements in strength and endurance in boys with Duchenne

26 Jun 2018

We are pleased to share an update from ReveraGen about its Vamorolone clinical trial. Vamorolone is an alternative treatment to existing steroids that aims to maximise the benefits while reducing the side effects. In 2014, The Duchenne Research Fund helped fund the...

Most recent:

  • FDA approves first gene therapy for Duchenne
  • DRF highlights psychosocial research at parent information day
  • See the smart suit that is changing children’s lives
  • DRF co-founder raises £15,000 in first marathon
  • DRF-funded KineDMD study published in Nature Medicine and featured on BBC

More about our projects:

administrative post award clinical post complementary current drug development early stage facility gene therapy past post project research standards of care

Jump to:

  • Donate
  • Contact Us
  • Get involved
  • Gallery
  • Our projects
  • Our story
  • Privacy
  • Home
  • Donate
  • Contact Us
  • Get involved
  • Gallery
  • Our projects
  • Our story
  • Privacy
  • Home
  • Facebook
  • Twitter
  • Instagram
Copyright © 2023 The Duchenne Research Fund. Registered Charity No. 1119068. Website by Sheli Rodney